Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Thomas

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Leukemia & Lymphoma|October 10, 2009
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategyDeborah A Thomas, Farhad Ravandi, Michael Keating, et al.
American Journal of Hematology|May 16, 2013
Late extramedullary recurrence of adult onset Burkitt's lymphoma mimicking peritoneal carcinomatosisPreetesh Jain, Ohad Benjamini, Ellen Schlette, et al.
Reviews in Clinical and Experimental Hematology|August 28, 2002
Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectivesStefan Faderl, Guillermo Garcia-Manero, Deborah A Thomas, et al.
Current Oncology Reports|June 7, 2012
Philadelphia-positive acute lymphoblastic leukemia: current treatment optionsTheresa Liu-Dumlao, Hagop Kantarjian, Deborah A Thomas, et al.
Cancer|January 20, 2011
Experience with rituximab immunotherapy as an early intervention in patients with Rai stage 0 to II chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Susan O'Brien, et al.
Cancer|November 27, 2004
New approaches in the treatment of myelofibrosisBryan T Hennessy, Deborah A Thomas, Francis J Giles, et al.
Cancer|August 23, 2008
Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemiaSusan O'Brien, Deborah A Thomas, Farhad Ravandi, et al.
Ear and Hearing|August 22, 2023
Use of Socioeconomic Demographic Data in Studies on Pediatric Unilateral Hearing Loss: A Scoping ReviewAmy L Zhang, Tinna-Sólveig F Kosoko-Thoroddsen, Deborah A Thomas, et al.
American Journal of Clinical Pathology|October 23, 2009
Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometryTariq Muzzafar, L Jeffrey Medeiros, Sa A Wang, et al.
Cancer|March 20, 2002
Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimenMary A Weiser, Susan O'Brien, Deborah A Thomas, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|October 10, 2009
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategyDeborah A Thomas, Farhad Ravandi, Michael Keating, et al.
American Journal of Hematology|May 16, 2013
Late extramedullary recurrence of adult onset Burkitt's lymphoma mimicking peritoneal carcinomatosisPreetesh Jain, Ohad Benjamini, Ellen Schlette, et al.
Reviews in Clinical and Experimental Hematology|August 28, 2002
Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectivesStefan Faderl, Guillermo Garcia-Manero, Deborah A Thomas, et al.
Current Oncology Reports|June 7, 2012
Philadelphia-positive acute lymphoblastic leukemia: current treatment optionsTheresa Liu-Dumlao, Hagop Kantarjian, Deborah A Thomas, et al.
Cancer|January 20, 2011
Experience with rituximab immunotherapy as an early intervention in patients with Rai stage 0 to II chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Susan O'Brien, et al.
Cancer|November 27, 2004
New approaches in the treatment of myelofibrosisBryan T Hennessy, Deborah A Thomas, Francis J Giles, et al.
Cancer|August 23, 2008
Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemiaSusan O'Brien, Deborah A Thomas, Farhad Ravandi, et al.
Ear and Hearing|August 22, 2023
Use of Socioeconomic Demographic Data in Studies on Pediatric Unilateral Hearing Loss: A Scoping ReviewAmy L Zhang, Tinna-Sólveig F Kosoko-Thoroddsen, Deborah A Thomas, et al.
American Journal of Clinical Pathology|October 23, 2009
Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometryTariq Muzzafar, L Jeffrey Medeiros, Sa A Wang, et al.
Cancer|March 20, 2002
Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimenMary A Weiser, Susan O'Brien, Deborah A Thomas, et al.
Pageof 11